<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="307981">
  <stage>Registered</stage>
  <submitdate>28/05/2009</submitdate>
  <approvaldate>16/06/2009</approvaldate>
  <actrnumber>ACTRN12609000460202</actrnumber>
  <trial_identification>
    <studytitle>Denture Stomatitis: cetylpyridinium chloride treatment with control group</studytitle>
    <scientifictitle>Denture stomatitis patients treated with cetiypyridinium chloride mouthwashes  compared to a control group in order to assess its efficacy</scientifictitle>
    <utrn />
    <trialacronym>DS-CPC</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Denture Stomatitis</healthcondition>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Once stablished the diagnosis of denture stomatitis, patients will be randomly allocated to one of two experimental groups. All patients will receive hygiene instructions and asked to avoid nocturnal use of their prosthesis. An appropriate toothbrush will be provided and a proper hygiene technique will be demonstrated and practiced once at the start of trial and reinforced at each control appointment.  Test group will be given cetylpyridinium chloride and directions to mouthwash 3 times daily, during one minute, three weeks long. Control group will be followed with no other intervention but the hygiene instructions.</interventions>
    <comparator>Control group will be followed with no other intervention for three weeks also.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Clinical improvement, measured according to the clinical parameters initially stablished - intensity and extent of mucosal erythema. Erythema intensity will be classified according to a coloured scale of eight grades varying from pale pink to bloody red. Extension of erythema will be objectively measured in square centimeters with the aid of digitized pictures and categorized in four classes: up to 25%; between 25 and 50%; between 50 and 75% and above 75% of the palate mucosa involved.</outcome>
      <timepoint>starting date, day 21, day 35</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Colony forming units will be counted in Petri dishes with appropriate medium for growing Candida species. Sample collection will be performed with cytobrushes from palate mucosa and the prosthesis basis. These samples will be progressive diluted and dispensed in drops on the Petri dishes. Dishes will be incubated at 37oC to be read in 24, 48 and 72 hours.</outcome>
      <timepoint>starting date, day 21, day 35</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Removable dental prosrthesis wearers
Proper diagnosis of denture stomatitis</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>No history of antifungal use in the last 6 months
Negative medical history for radiotherapy, chemotherapy or immunodeficiency</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Elegible patients will be properly instructed and asked to sign an Informed Consent. Every patient will be treated, through hygiene instructions and changing in the habits of prosthesis utilization. Test group will additionally use a cetylpyridinium chloride mouthwash. One researcher will be responsible for enrolling the sibjects and generate the sequence of allocation. The clinical researcher will receive the patient, open the sealed envelope with the allocation group and proceed with the methodology as a control or test group patient.</concealment>
    <sequence>Allocation between the two groups will be randomized with the aid of a computer program.</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/05/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>32</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Brazil</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Sao Paulo University</primarysponsorname>
    <primarysponsoraddress>Av Prof Lineu Prestes, 2227
Cidade Universitaria
Sao Paulo
CEP 05508-000</primarysponsoraddress>
    <primarysponsorcountry>Brazil</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Sao Paulo University</fundingname>
      <fundingaddress>Av Prof Lineu Prestes, 2227
Cidade Universitaria
Sao Paulo
CEP 05508-000</fundingaddress>
      <fundingcountry>Brazil</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The main purpose of the trial is to verify the efficacy of cetylpyridinium chloride mouthwashes in the treatment of denture stomatitis utilizing as outcome measures clinical and micological parameters, i.e., extent and intensity of mucosal erythema and colony forming units of Candida species.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Research Ethics Committee of Sao Paulo University School of Dentistry</ethicname>
      <ethicaddress>Av Prof Lineu Prestes, 2227
Cidade Universitaria
Sao Paulo
CEP 05508-000</ethicaddress>
      <ethicapprovaldate>12/05/2008</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Brazil</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Norberto Nobuo Sugaya</name>
      <address>Av Prof Lineu Prestes, 2227
Cidade Universitaria
Sao Paulo
CEP 05508-000</address>
      <phone>+55 11 30917883</phone>
      <fax>+55 11 30917883</fax>
      <email>nnsugaya@usp.br</email>
      <country>Brazil</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Juliana Seo</name>
      <address>Alha Elias Abibe Street, 65
Parque dos Principes
Osasco
Postal Code: 06030-300</address>
      <phone>+55 11 35910033</phone>
      <fax />
      <email>juseo@uol.com.br</email>
      <country>Brazil</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Juliana Seo</name>
      <address>Alha Elias Abibe Street, 65
Parque dos Principes
Osasco
Postal Code: 06030-300</address>
      <phone>+55 11 35910033</phone>
      <fax />
      <email>juseo@uol.com.br</email>
      <country>Brazil</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>